SHG — Singular Health Cashflow Statement
0.000.00%
- AU$71.69m
- AU$67.06m
- AU$0.95m
Annual cashflow statement for Singular Health, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | C2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | — | 0.38 | 0.376 | 0.418 | 0.987 |
Other Operating Cash Flow | |||||
Cash from Operating Activities | -0.548 | -1.91 | -2.91 | -2.4 | -2.44 |
Capital Expenditures | -0.032 | -0.311 | -0.012 | -0.022 | -0.074 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -0.228 | -0.3 | -0.005 | -0.613 | 0.07 |
Acquisition of Business | |||||
Sale of Business | |||||
Change in Net Intangibles | |||||
Cash from Investing Activities | -0.259 | -0.611 | -0.017 | -0.635 | -0.004 |
Financing Cash Flow Items | — | — | — | 0.359 | -0.258 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.951 | 6.52 | -0.069 | 2.59 | 3.21 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.131 | 4.01 | -3 | -0.448 | 0.764 |